Loading page…

Park Medi World Limited (PARKHOSPS) · mywealthgrid

Park Medi World Limited

NSE:PARKHOSPS BSE:PARKHOSPS

HealthcareHealthcare ServicesNIFTY MICROCAP 250 +1

₹270.8

-1.51%1 Oct close

Mkt cap

₹11,696 Cr

Watch Alert Compare

About

Park Medi World Limited operates hospital-based healthcare services with a consolidated revenue base of ₹475.71 Cr (Jun 2026) and market cap of ₹12,151.51 Cr. The company comprises at least two operating segments—a smaller standalone unit (₹33.53 Cr revenue) and a larger consolidated entity—generating combined net profit of ₹88.59 Cr at 26.51% operating margin. It ranks as a mid-sized healthcare provider with capital efficiency (ROE 16.7%) and minimal financial leverage (D/E 0.11).

Face value: ₹2

Market cap

₹11,696 Cr

P/E

45.3×

P/B

5.8×

Dividend yield

ROE

16.7%

ROCE

21.4%

Debt / equity

0.11

OPM

26.5%

EPS (TTM)

₹6.0

Book value

₹46.8

52-week high

—

52-week low

Key insights

Company research notes and source-linked reviews

Key risks

Extreme valuation: PE of 47.08 leaves no buffer for earnings misses; verify forward earnings visibility and growth rate justifying this multiple.
Standalone-consolidated margin divergence: Standalone unit posted 3.82% OPM (Jun 2026) versus consolidated 26.51%; investigate whether this signals structural weakness, accounting complexity, or temporary distress.
Minimal institutional participation: FII 0.82% and DII 8.95% indicate very low confidence among sophisticated investors; clarify why institutions avoid the stock despite decent fundamentals.
Price at range top: ₹281.35 sits near the 52-week high (₹299.3), creating downside risk if valuations compress.

Generated analysis · source review pending

Growth drivers

Consolidated revenue of ₹475.71 Cr provides base to absorb fixed costs and drive margin expansion if utilisation or scale increases.
D/E ratio of 0.11 creates financial capacity for facility expansion, acquisitions, or capex to grow the ₹475.71 Cr revenue base.
ROE of 16.7% indicates capital generates returns above cost; retention and reinvestment of earnings can compound growth.
Standalone OPM volatility (39.28% in Dec 2025 vs. 3.82% in Jun 2026) suggests operational normalisation could recover blended margins if the unit stabilises.

Generated analysis · source review pending

192 historical price candles were omitted because the exchange source has not been verified.

₹270.8-1.7%1Y

Quick read

rule-based

Pros

+Strong return on equity of 19.3% (3-yr avg)
+High return on capital employed of 22.8%
+Healthy operating margin of 26.5%
+High promoter holding of 82.9% with no pledge

Cons

No red flags triggered.

Research score

Structured signal from quality, growth, valuation and momentum.

40/100

Business quality: 62
Growth: 27
Valuation: 31

Revenue & net profit

₹ crore, by fiscal year

RevenuePAT

Margins

% of revenue, by fiscal year

OPMPAT margin

Peers

Comparable companies from the narrowest available industry classification.

Part ofNIFTY MICROCAP 250 NIFTY TOTAL MARKET

Screen this industry

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Consolidated Standalone

Consolidated figures · ₹ crore

₹ Cr	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	1,255	1,231	1,394	1,679
COGS	—	—	—	296
Gross profit	—	—	—	1,384
	864	921	1,021	939
	390	310	372	444
OPM %	31.1%	25.2%	26.7%	26.5%
Depreciation	41	51	58	62
Interest	51	70	60	59
	18	32	32	32
Profit before tax	—	—	—	355
Tax	93	82	79	81
Tax %	—	—	—	22.9%
	228	152	213	274
PAT margin %	18.2%	12.4%	15.3%	16.3%
EPS (₹)	—	—	—	6.9
EPS adjusted (₹)	—	—	—	6

₹ Cr	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	77	77	77	77	86
Reserves	380	610	806	993	1,936
Minority interest	87	43	53	57	82
	503	557	633	622	228
	246	306	344	385	481
Total equity & liabilities	1,293	1,593	1,912	2,134	2,813
	444	518	785	842	1,309
CWIP	29	5	32	37	123
Investments	0	0	0	0	0
	820	1,070	1,095	1,255	1,381
Total assets	1,293	1,593	1,912	2,134	2,813

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Consolidated Standalone

Consolidated figures

Ratio	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	—	—	—	82.4%
EBITDA margin %	31.1%	25.2%	26.7%	26.5%
EBIT margin %	27.9%	21.1%	22.5%	22.7%
PAT margin %	18.2%	12.4%	15.3%	16.3%
Working capital
Receivable days	168	151	161	129
Inventory days	1	1	1	4
Payable days	—	—	—	134
NWC days	—	—	—	-2
Leverage
Current ratio	1.57	1.79	1.86	2.06
Debt to EBITDA	1.43	2.04	1.67	0.51
Debt to equity	0.81	0.72	0.58	0.11
Interest coverage	7.3	4.1	5.8	7
Asset turnover	0.79	0.64	0.65	0.6
Return ratios
Return on assets %	14.3%	7.9%	10%	9.7%
Return on capital employed %	34.3%	23.7%	23.4%	21.4%
Return on equity %	33.2%	17.2%	19.9%	13.5%

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	82.89%	82.89%	82.89%	82.89%
	1.97%	1.28%	0.86%	0.82%
	6.18%	8.58%	8.95%	8.95%
	0.48%	0.2%	0.3%	0%
	8.48%	7.05%	7%	7.34%
No. of shareholders	2,22,731	1,14,600	50,863	52,428

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

Portfolio month

Schemes holding

across 5 fund houses

Held by these funds

5.29%

of the company's equity

All mutual funds

5.66%

shareholding pattern, Jun 2026

Portfolios as of

August 2026

compared with July 2026

17 schemes · 5 fund houses

		Shares
Portfolio of Kotak Multi Asset Allocation Fund	Kotak Mahindra Mutual Fund	89.74 L	257.14	1.68%	2.078%	-0
Portfolio of Kotak Contra Fund	Kotak Mahindra Mutual Fund	33.52 L	96.05	1.74%	0.776%	-0
Portfolio of Kotak ELSS Tax Saver Fund	Kotak Mahindra Mutual Fund	26.25 L	75.22	1.18%	0.608%	-0
Portfolio of Kotak Consumption Fund	Kotak Mahindra Mutual Fund	19.57 L	56.07	3.24%	0.453%	-3 L
Portfolio of Kotak Special Opportunities Fund	Kotak Mahindra Mutual Fund	15.63 L	44.8	2.63%	0.362%	-0
Portfolio of Kotak Infrastructure & Economic Reform FundNEW	Kotak Mahindra Mutual Fund	12.34 L	35.35	1.42%	0.286%	—
Portfolio of Kotak Healthcare Fund	Kotak Mahindra Mutual Fund	9 L	25.79	3.36%	0.208%	-0
Small Cap FundNEW	Helios Mutual Fund	5.86 L	16.78	0.97%	0.136%	—

1–8 of 17

1 / 3

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

1

Board meeting to consider results3 Aug 2026

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

90 announcementsExport CSV

28 Sept 2026, 1:06 pmInsider Trading / SAST

Closure of Trading Window

Closure of Trading Window PDF

Loading announcements…

Ratio	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	—	—	—	82.4%
EBITDA margin %	31.1%	25.2%	26.7%	26.5%
EBIT margin %	27.9%	21.1%	22.5%	22.7%
PAT margin %	18.2%	12.4%	15.3%	16.3%
Working capital
Receivable days	168	151	161	129
Inventory days	1	1	1	4
Payable days	—	—	—	134
NWC days	—	—	—	-2
Leverage
Current ratio	1.57	1.79	1.86	2.06
Debt to EBITDA	1.43	2.04	1.67	0.51
Debt to equity	0.81	0.72	0.58	0.11
Interest coverage	7.3	4.1	5.8	7
Asset turnover	0.79	0.64	0.65	0.6
Return ratios
Return on assets %	14.3%	7.9%	10%	9.7%
Return on capital employed %	34.3%	23.7%	23.4%	21.4%
Return on equity %	33.2%	17.2%	19.9%	13.5%

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Max Healthcare Institute LimitedMAXHEALTHMAXHEALTH	₹91,573 Cr	₹95,052 Cr	₹8,712 Cr	₹2,318 Cr	26.8%	₹1,457 Cr	17.2%	13.8%	14.3%	-110
Manipal Health Enterprises LimitedMANIPALHOSMANIPALHOS	₹91,552 Cr	₹1,02,105 Cr	₹10,336 Cr	₹2,611 Cr	25.3%	₹917 Cr	8.9%	12.5%	12.8%	38
Fortis Healthcare LimitedFORTISFORTIS	₹59,268 Cr	₹62,140 Cr	₹9,506 Cr	₹2,131 Cr	22.8%	₹1,048 Cr	11.7%	13%	11.1%	-99
Aster Dm Healthcare LimitedASTERDMASTERDM	₹36,728 Cr	₹37,429 Cr	₹4,876 Cr	₹958 Cr	19.4%	₹319 Cr	9.2%	11.9%	9.7%	-112
Global Health LimitedMEDANTAMEDANTA	₹36,498 Cr	₹37,688 Cr	₹4,683 Cr	₹979 Cr	20.8%	₹556 Cr	12.6%	16.9%	15.1%	-26
Narayana Hrudayalaya Ltd.NHNH	₹35,594 Cr	₹40,460 Cr	₹9,072 Cr	₹1,749 Cr	20.5%	₹816 Cr	10.2%	15.1%	19.7%	-181
Krishna Institute Of Medical Sciences LimitedKIMSKIMS	₹29,457 Cr	₹32,701 Cr	₹4,213 Cr	₹833 Cr	20.5%	₹205 Cr	6.2%	9.5%	11%	-50
Dr. Agarwal's Health Care LimitedAGARWALEYEAGARWALEYE	₹15,420 Cr	₹15,578 Cr	₹2,207 Cr	₹612 Cr	27.4%	₹148 Cr	8.1%	10.1%	6.8%	-76
Rainbow Childrens Medicare LimitedRAINBOWRAINBOW	₹13,003 Cr	₹13,003 Cr	₹1,820 Cr	₹575 Cr	32%	₹285 Cr	16.5%	18.2%	17.9%	-73
Park Medi World LimitedPARKHOSPSPARKHOSPS	₹11,696 Cr	₹11,924 Cr	₹1,679 Cr	₹444 Cr	26.5%	₹258 Cr	16.3%	21.4%	16.7%	-2
Healthcare Global Enterprises LimitedHCGHCG	₹9,984 Cr	₹10,895 Cr	₹2,627 Cr	₹480 Cr	18.3%	₹23 Cr	0.9%	9.1%	1.2%	-93
Yatharth Hospital & Trauma Care Services LimitedYATHARTHYATHARTH	₹9,965 Cr	₹10,218 Cr	₹1,334 Cr	₹310 Cr	24.2%	₹174 Cr	14.1%	12.3%	10%	-26

Date	Category	Subject	Filing
28 Sept 2026, 1:06 pm	Insider Trading / SAST Closure of Trading Window	Closure of Trading Window	PDF
22 Sept 2026, 6:01 pm	AGM/EGM AGM	Shareholder Meeting / Postal Ballot-Scrutinizer''s Report	PDF
22 Sept 2026, 5:43 pm	AGM/EGM AGM	Shareholder Meeting / Postal Ballot-Outcome of AGM	PDF
22 Sept 2026, 9:26 am	Company Update Press Release / Media Release	Announcement under Regulation 30 (LODR)-Press Release / Media Release	PDF
16 Sept 2026, 4:22 pm	Company Update Analyst / Investor Meet	Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation	PDF
16 Sept 2026, 10:20 am	Company Update General	Operations And Management Agreement With Axis Educational Society	PDF
8 Sept 2026, 7:53 pm	Company Update Acquisition	Announcement under Regulation 30 (LODR)-Acquisition	PDF
5 Sept 2026, 3:31 pm	Company Update Analyst / Investor Meet	Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation	PDF

₹ Cr	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	155	195	361	191	329
	-248	-180	-255	-91	-333
	163	2	-130	-74	121
Net cash flow	70	17	-23	26	116
Free cash flow	—	—	—	—	209
CFO / Operating profit %	—	50%	116.5%	51.4%	74.1%

Park Medi World Limited

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Ratios

Shareholding

F&O

Not in the F&O segment

Fund holders

Documents

Announcements

Events

1

Announcements

Not in the F&O segment

1

Announcements

Offer and rights documents

Investor Presentation and earnings call

Compounded sales growth

Compounded profit growth

Return on equity

Park Medi World Limited

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Ratios

Ratio timeline

Shareholding

Quarterly record

F&O

Not in the F&O segment

Fund holders

Documents

Announcements

Events

Board meetings1

Announcements

Ratio timeline

Not in the F&O segment

Board meetings1

Announcements

Quarterly record

Offer and rights documents

Investor Presentation and earnings call

Board and management

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth

Return on equity

1

1